Balkan Pharmaceuticals is a pharmaceutical company founded in 2007.
The mission of the company is to help people live longer, be healthier and happier. In order to achieve these objectives, the company uses the latest results of researches in pharmaceutical area, produces and provides high quality medicines for the prevention and treatment of various diseases.
Balkan Pharmaceuticals has set as its main objective, to produce only quality medicines, which also would have an acceptable price, based on the purchasing power of the ordinary citizen. And by important donations, offered to medical institutions the company represents a model of corporate social responsibility, alternatively contributing to the achievement of the task.
The company works on Moldovan market since 2007. In January 2009, it had registered the first medicines on Ukrainian market. In October 2010, Balkan Pharmaceuticals has won the right to deliver medicines for the public medical institutions of Moldova. At the same time, the company started to invest in its new manufacturing complex in Singera.
Currently, the company Balkan Pharmaceuticals has 80 employees working at its factory in Chisinau. Doctors, chemists, technologists, programmers, engineers - all of them are highly qualified specialists. Company's goal is to create in Moldova a qualified, competent staff that would correspond to all rigors of the work related to pharmaceutical production. That's why, in order to raise and maintain the qualifications of the employees, periodically are attracted professionals from abroad - Romania, Ukraine and EU.
At the moment, the company produces 127 names of medicines, including antitumor preparations - 29 positions, hormonal - 21 positions, preparations with effect on nervous system (15), on the cardiovascular system (16), digestive (13), preparations with anti-inflammatory, analgesic effect (14), etc.
Balkan Pharmaceuticals is an important Romanian investment. Besides the factory in Chisinau, the company has invested nearly 26 million euro for the construction of a new factory in Sangera. The building is well equipped, having advanced systems that are unique in Europe. The factory will allow the increase of the production volume, will increase the number of employees up to 400 highly qualified people, but also will allow the extension to CIS and EU markets.
Unlike other types of manufacturers, the pharmaceutical field has strict requirements for the production process. Even if now, in Moldova the GMP standards (Good Manufacturing Practices) aren't required, the factory in Sangera, with an area of over 12 thousand square meters, meets all the requirements.
At the factory where installed a lot of advanced systems, designed to ensure its proper functioning and provide a pleasant and safe working environment for the professionals. The production of medicines is a very complex process and requires ideal accuracy. The process is monitored remotely, via an automated and advanced monitoring system, and the access-control system ensures the sterility of the finished product and of the raw materials. Engineers involved in the project say that in Moldova, currently, there are no such systems, from technical point of view.
This makes them think that Balkan Pharmaceuticals, besides the investment in such a great project, has imported know-how on the Moldovan market and also made a technical contribution to the pharmaceutical industry.
Balkan Pharmaceuticals company sells 98% of its medicines on Moldovan market. Company's medicines are highly rated on the markets of Russia and Ukraine. After the transfer to the factory in Sangera, the company aims to enter the EU market.
AUTHENTICATE PRODUCTS Balkan pharmaceuticals :